| scholarly article | Q13442814 |
| P50 | author | Charles Grose | Q57329554 |
| Ann Arvin | Q4766238 | ||
| P2093 | author name string | J F Moffat | |
| W T Ruyechan | |||
| J Hay | |||
| R A Santos | |||
| N L Cole | |||
| J A Padilla | |||
| C C Hatfield | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| P304 | page(s) | 306-317 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice | |
| P478 | volume | 275 |
| Q42020619 | A case for varicella vaccination in the immunosuppressed |
| Q33923167 | A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008. |
| Q41909025 | Autophagy and the effects of its inhibition on varicella-zoster virus glycoprotein biosynthesis and infectivity |
| Q36674719 | Bioinformatics of varicella-zoster virus: single nucleotide polymorphisms define clades and attenuated vaccine genotypes |
| Q24816088 | Case report: occupationally related recurrent varicella (chickenpox) in a hospital nurse |
| Q36099097 | Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication |
| Q34436222 | Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype |
| Q43251025 | Complete DNA sequences of two oka strain varicella-zoster virus genomes |
| Q36433940 | Defensive Perimeter in the Central Nervous System: Predominance of Astrocytes and Astrogliosis during Recovery from Varicella-Zoster Virus Encephalitis |
| Q37033241 | Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry |
| Q41136589 | Differential expression of Marek's disease virus (MDV) late proteins during in vitro and in situ replication: role for pUL47 in regulation of the MDV UL46-UL49 gene locus. |
| Q37596465 | Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells |
| Q40026942 | Egress of light particles among filopodia on the surface of Varicella-Zoster virus-infected cells |
| Q41359463 | Enumeration of an extremely high particle-to-PFU ratio for Varicella-zoster virus |
| Q35101360 | Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection |
| Q37596576 | Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo |
| Q38609902 | Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection |
| Q33591823 | Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection |
| Q42601933 | Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. |
| Q35704301 | Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping |
| Q39753125 | Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells |
| Q39761542 | In vitro replication of varicella-zoster virus in human retinal pigment epithelial cells |
| Q40478161 | Incorporation of three endocytosed varicella-zoster virus glycoproteins, gE, gH, and gB, into the virion envelope |
| Q33622464 | Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability |
| Q24307918 | Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread |
| Q33791387 | Molecular mechanisms of varicella zoster virus pathogenesis |
| Q39846393 | Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo |
| Q34977329 | Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo |
| Q33853728 | Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus |
| Q37334450 | New variant of varicella-zoster virus |
| Q36423681 | Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D |
| Q24598332 | Pangaea and the Out-of-Africa Model of Varicella-Zoster Virus Evolution and Phylogeography |
| Q90466201 | Personalized viral genomic investigation of herpes simplex virus 1 perinatal viremic transmission with dual fatality |
| Q39581584 | Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet |
| Q34349663 | Phosphorylation by the varicella-zoster virus ORF47 protein serine kinase determines whether endocytosed viral gE traffics to the trans-Golgi network or recycles to the cell membrane |
| Q34110122 | Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination |
| Q42272374 | Post-mortem diagnosis, of cytomegalovirus and varicella zoster virus co-infection by combined histology and tissue molecular biology, in a sudden unexplained infant death |
| Q39698466 | Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo |
| Q37256702 | Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis |
| Q42427401 | Reinfection of Varicella zoster in a vaccinated adult |
| Q41877202 | Replication of varicella-zoster virus in human skin organ culture |
| Q45370931 | Sequence analysis of the glycoprotein E gene of varicella-zoster virus strains of clades 1, 3 and 5 |
| Q28732494 | Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination |
| Q44064006 | Studies on shingles, is the virus ordinary chickenpox virus? |
| Q40107009 | Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 Deletion |
| Q35947774 | The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor |
| Q33554456 | The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection |
| Q45729323 | The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades |
| Q40213235 | The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator |
| Q33833934 | Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model |
| Q39604242 | Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression |
| Q62899300 | Viral induced fusion and syncytium formation: measurement by the Kolmogorov–Smirnov statistical test |
Search more.